Investing.com - 2Seventy Bio (NASDAQ: TSVT) reported first quarter EPS of $-1.010, $0.26 worse than the analyst estimate of $-0.750. Revenue for the quarter came in at $12.4M versus the consensus estimate of $14.8M.
2Seventy Bio's stock price closed at $4.96. It is down -17.200% in the last 3 months and down -56.220% in the last 12 months.
2Seventy Bio saw 1 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See 2Seventy Bio's stock price’s past reactions to earnings here.
According to InvestingPro, 2Seventy Bio's Financial Health score is "good performance".
Check out 2Seventy Bio's recent earnings performance, and 2Seventy Bio's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar